Citi Eyes China Brokerage Unit Licence as Soon as This Month, Sources Say
Citigroup is closing in on a milestone that has taken the better part of four years to reach. The U.S. banking giant expects to receive regulatory approval for its wholly-owned China brokerage business as soon as this month, according to two people familiar with the matter, a development that would mark the final step in a licensing process the bank first set in motion in late 2021. Citi declined to comment on the timeline when approached, but the expected approval has not been previously reported and would put the bank on track to formally launch operations in one of the world’s most competitive and increasingly lucrative securities markets.
The brokerage unit, if approved as expected, would allow Citi to operate as a wholly foreign-owned securities firm on the Chinese mainland, giving it direct access to underwrite equity and debt offerings, handle brokerage services, and provide advisory work without needing a local joint venture partner. That distinction matters enormously in China’s financial services sector, where foreign firms have historically had to share control and profits with domestic partners before recent regulatory changes opened the door to full ownership. Citi applied for its licence in late 2021, part of a broader push by the bank to expand its footprint in China’s securities market at a time when several other Wall Street institutions were making similar moves.
According to one of the sources, Citi has already been building out the team ahead of getting the green light, and the bank aims to roughly double headcount at the unit to around 100 people by the end of this year. That kind of staffing commitment before formal approval suggests Citi is confident enough in the timeline to start onboarding talent rather than waiting until the licence is fully in hand, a pattern that mirrors how the bank approached earlier stages of this same application process over the past several years.
Once operational, Citi’s new brokerage arm would compete directly with other Wall Street firms that have already secured similar licences in China, including JPMorgan, Goldman Sachs and Morgan Stanley. Those firms have spent recent years building out onshore securities trading and underwriting businesses in China, chasing a slice of a market that has grown steadily larger and more profitable even as broader U.S.-China relations have remained complicated. Citi entering that fray now, years after some of its rivals established a foothold, means it will need to work to catch up on relationships, deal flow and local market credibility that competitors have already had time to build.
The sector focus for Citi’s planned unit gives a clearer picture of where the bank sees opportunity. According to one source, the new business will concentrate on technology, healthcare, consumer and financial institutions sectors, specifically targeting China’s established corporate leaders alongside emerging players in artificial intelligence and semiconductor manufacturing. That’s a notable emphasis given how central AI and chip development have become to China’s broader industrial and economic strategy in recent years, and it signals Citi wants exposure to some of the fastest-growing corners of Chinese capital markets rather than just serving legacy state-linked enterprises.
The timing of this expected approval lines up with a broader trend playing out in Chinese equity markets right now. A growing number of Chinese technology and other companies have been tapping domestic equity markets more actively, creating exactly the kind of underwriting and advisory demand that a newly licensed brokerage would want to capture early. For Citi, getting the licence approved this month rather than facing further delays would let the bank position itself to participate in that wave of activity rather than watching from the sidelines while competitors handle the deals.
This isn’t Citi’s first attempt at cracking the wholly-owned brokerage model in China, and the road to this point has been unusually long even by the standards of Chinese financial regulatory approvals. The bank previously explored acquiring Credit Suisse Securities China as a faster route to a wholly-owned licence, but that path closed once UBS acquired Credit Suisse globally and absorbed full control of UBS Securities in the process. Citi also had an earlier joint venture arrangement with Orient Securities, in which it held a 33.3 percent stake starting in 2012, but the bank withdrew from that partnership in 2019 after failing to negotiate its way up to a controlling 51 percent stake. Those setbacks pushed Citi toward pursuing a standalone, wholly-owned licence instead, a process it formally kicked off in December 2021.
Beyond the brokerage licence itself, Citi has been signaling broader ambitions across its Asia operations more generally. The bank this week announced a 25 percent headcount increase across South Africa, Europe and Asia specifically to serve the outbound banking needs of its North Asian clients, including businesses based in mainland China looking to expand internationally. That kind of parallel investment suggests Citi’s China strategy isn’t limited to just the domestic brokerage business, but extends to strengthening the infrastructure needed to serve Chinese corporate clients as they look outward for financing, deals and banking relationships beyond their home market.
Not every foreign financial firm has found China’s market easy to navigate profitably, and it’s worth noting that context alongside Citi’s expansion plans. Some international firms have exited the Chinese market in recent years, citing an intensely competitive business environment where domestic Chinese brokerages hold significant structural advantages in terms of existing client relationships, local regulatory familiarity and scale. Asset manager Fidelity International, for instance, has reportedly been reassessing parts of its Chinese operations amid similar competitive pressures. Citi will be entering this business not just against well-established Wall Street peers but also against dominant domestic Chinese brokerages that have deep, long-standing relationships with corporate issuers and government-linked entities.
Still, the strategic logic behind Citi’s push is straightforward. China remains the world’s second-largest economy, and its capital markets, despite periodic volatility and regulatory shifts, continue to represent one of the largest pools of underwriting and advisory fee opportunity globally. For a bank like Citi that has been actively reshaping its global footprint in recent years, sometimes retreating from consumer banking markets while doubling down on institutional and corporate services, securing full control over a China brokerage operation fits a broader pattern of prioritizing higher-margin, institutional-focused business lines over lower-margin retail operations.
If the approval does come through this month as expected, it would cap off a four-year regulatory journey and put Citi in direct competition for some of the most sought-after underwriting and advisory mandates tied to China’s technology and industrial sectors. Whether the bank can translate that licence into meaningful market share against entrenched competitors, both foreign and domestic, will likely take considerably longer than the approval process itself did to become clear.
